Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4 Registration of securities issued in business combination transactions
- 10.4 Exhibit 10.4
- 10.31 Exhibit 10.31
- 10.32 Exhibit 10.32
- 10.33 Exhibit 10.33
- 10.34 Exhibit 10.34
- 10.35 Exhibit 10.35
- 10.36 Exhibit 10.36
- 10.37 Exhibit 10.37
- 10.38 Exhibit 10.38
- 10.39 Exhibit 10.39
- 23.1 Exhibit 23.1
- 23.2 Exhibit 23.2
- 99.3 Exhibit 99.3
- 99.4 Exhibit 99.4
- 99.5 Exhibit 99.5
- 99.6 Exhibit 99.6
SEEL similar filings
Filing view
External links
Exhibit 99.5
August 29, 2018
Apricus Biosciences, Inc.
11975 El Camino Real, Suite 300
San Diego, CA 92130
Consent to Reference in Proxy Statement/Prospectus/Information Statement
Apricus Biosciences, (the "Company") is filing a Registration Statement on Form S-4 (Registration No. 333- ) with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the "Securities Act"). In connection therewith, I hereby consent, pursuant to Rule 438 of the Securities Act, to the reference to me in the proxy statement/prospectus/information statement included in such registration statement as a future member of the board of directors of the Company.
Sincerely,
/s/ Raj Mehra
Raj Mehra, Ph.D.